Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.

Pathology - 1 Feb 2023

Coombes Caitlin, Horikawa Keisuke, Jain Sanjiv, Jiang Simon, Lim Jun Hee, Saxena Kartik, Shadbolt Bruce, Smyth Lillian, Tobin Joshua, Talaulikar Dipti

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) is the most common form of B-cell non-Hodgkin lymphoma (B-NHL) with significant morbidity and mortality despite advancements in treatment. Lymphoma and autoimmune disease both result from breakdowns in normal cell regulatory pathways, and epidemiological studies have confirmed both that B-NHL is more likely to develop in the setting of autoimmune diseases and vice versa. Red...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to Autoimmunity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to B-Lymphocytes

Share to Lymphoma, Large B-Cell, Diffuse

Share to Mutation

Source

Identifiers

PMID: 36420560
DOI: 10.1016/j.pathol.2022.07.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.PMID 36420560Read ↗

Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and ManagementSemantic proximity Read ↗

Clinical features and immunophenotypes of double-hit diffuse large B-cell lymphomaSemantic proximity Read ↗

Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.Semantic proximity Read ↗

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) or AUTOIMMUNE LYMPHOPROLIFERATIVE IMMUNODEFICIENCY (ALPID): THE ONGOING DIAGNOSTIC DILEMA: A CASE SERIES.Semantic proximity Read ↗

The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.Semantic proximity Read ↗

Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.Semantic proximity Read ↗

Clinical Features and Lymphocyte Immunophenotyping Analysis in Primary Immunodeficiency Patients With Non-transplant Lymphoproliferative DisordersSemantic proximity Read ↗

Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity.Semantic proximity Read ↗

Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic LandscapeSemantic proximity Read ↗

Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody.Semantic proximity Read ↗

Lymphocyte predominant Hodgkin lymphoma, antigen-driven after all?Semantic proximity Read ↗

Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.